Legend Biotech Corp. (LEGN)
34.86
+1.38
(+4.11%)
USD |
NASDAQ |
Jun 10, 16:00
34.86
0.00 (0.00%)
After-Hours: 16:17
Legend Biotech EPS Diluted (Quarterly) : -0.2942 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Protagonist Therapeutics, Inc. | 0.0537 |
| AbbVie, Inc. | 0.3861 |
| Capricor Therapeutics, Inc. | -0.591 |
| Viking Therapeutics, Inc. | -1.37 |
| Arcutis Biotherapeutics, Inc. | -0.0873 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.46M |
| Revenue (Quarterly) | 306.01M |
| Total Expenses (Quarterly) | 360.47M |
| Enterprise Value | 5.775B |
| Gross Profit Margin (Quarterly) | 37.23% |
| Profit Margin (Quarterly) | -17.80% |
| Earnings Yield | -3.90% |
| Normalized Earnings Yield | -3.870 |